CHANGZHOU,China,Sept. 11,2024-- Trina Solar (Luxembourg) Holdings S.A.R.L.,a subsidiary of Trina Solar Co.,Ltd.,has secured a €150 million revolving credit facility from Banco Santander to accelerate
Sep 11, 2024
SHENZHEN,China,Sept. 11,2024-- Skyworth celebrates a huge win! It surpassed 36 million shipments of Google TVs and other Android TV OS devices globally this year. This incredible achievement not only
Sep 11, 2024
MACAU,Sept. 11,2024-- The first urban renewal project in Macau since its return to China,M8,officially commenced its soft opening on September 10,2024. The project is located just 50 meters from Senad
Sep 11, 2024
LOS ANGELES,Sept. 11,2024-- TTLife Oxygen Concentrator, is proud to announce its certification as a VARON-certified dealer of oxygen concentrators. This recognition solidifies TTLife\'s commitment to
Sep 11, 2024
DA NANG,Vietnam,Sept. 11,2024--Nestled along the serene shores of Non Nuoc Beach,Danang Marriott Resort & Spa,Non Nuoc Beach Villas has quickly become a haven for families seeking tranquility,rela
Sep 11, 2024
Mike Tyson will only be assessed the day before his fight with Jake Paul despite ongoing concerns over the 58-year-old's health.
Sep 9, 2024
The supermarket unveiled plans to invest £800m in more than 20 new stores by the end of the year.
Sep 9, 2024
TECNO AI vision propels emerging markets into the new age of AI with better localization for greater productivity and creativity,and more practical value.
Sep 9, 2024
OCI Global ("OCI",the "Company") has entered into a binding equity purchase agreement for the sale of 100% of its equity interests in its Global Methanol Business ("OCI Methan
Sep 9, 2024
RIYADH,Saudi Arabia,Sept. 9,2024-- The Saudi Authority for Data and Artificial Intelligence (SDAIA) will hold a press conference on Sunday,September 8,at the King Abdulaziz International Conference Ce
Sep 9, 2024
BERLIN,Sept. 9,2024-- Toshiba,a brand renowned for its over a century of excellence in craftsmanship and design,proudly presents the launch of its latest high-end offering,the Masterstroke Series,at t
Sep 9, 2024
The study involved end-stage oncology patients with no other suitable treatment options. In this Phase Ib study,Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed prelimina
Sep 9, 2024

© TopicFashion Privacy Policy Contact us